SlideShare ist ein Scribd-Unternehmen logo
1 von 1
Downloaden Sie, um offline zu lesen
Synaptic Changes in Neuronal Ceroid Lipofuscinosis
Variant Infantile Batten Disease
Richard Tuxworth, University of Birmingham, UK. r.i.tuxworth@bham.ac.uk
Megan O’Hare & Guy Tear, King’s College London, UK. guy.tear@kcl.ac.uk
What are synapses?
The brain contains billions of nerve cells. Each
makes thousands of connections with
neighbours at structures called synapses.
When an electrical impulse arrives at a
synapse special chemicals are released. These
are called neurotransmitters.
The chemicals cross over to the neighbouring
nerve cell. There are several types of
neurotransmitter chemicals. Some “excite” the
neighbour, other “inhibit” the neighbour.
If enough “exciting” chemicals arrive in a short
space of time, the neighbour will “fire” and an
electrical signal passes along the nerve cell.
1
2 Why are synapses interesting to study?
1. For neurodegenerative diseases
Synapses are one of the first things to
be affected in neurodegeneration
diseases. This happens in all forms of
neurodegeneration including inherited
forms like NCL and late onset forms like
Alzheimer’s disease.
We need to understand what is
happening and why to help design
effective therapies.
2. For developmental disorders
Synapses are changed in some
developmental disorders such as autism.
Changes occur during foetal
development or very early in childhood.
In some forms of autism nerve cells
grow too big and have too many
synapses. We don’t understand why this
leads to the behavioural differences in
autism.
In neurodegenerative diseases with very early onset (like the infantile forms of NCLs) the
changes to synapses must start very early on? Can we see any similarities to the changes
in developmental disorders?
3
How do we study synaptic change?
Many NCL studies use mice to help understand the disease. A mouse
brain is much less complex than a human’s but still contains many
billions of synapses.
As a simpler alternative, we are using
fruit flies to look for synaptic changes
in NCL.
Fruit flies have a much smaller and
simpler nervous system than a mammal
but their nerve cells work identically.
With fruit flies we can also use powerful
genetic tools. This allows us to manipulate
their genes in ways that are not possible
with mice.
4
What are we doing?
We made a fruit fly mutant which does not have the Cln7 gene.
We can are look at one particular nerve and see if the number of
synapses has changed.
We dissect the fruit flies
when they are maggots.
Then we look at the nerves
by microscopy.
The synapses are the small
red dots. More than 5,000
would fit on a pin head.
The rest of the nerve is
shown in green.
We use software to count
the synapses and measure
the size of the nerve.
5
What happens when there is no Cln7 ?
In flies without a Cln7 gene the nerve gets smaller and
the number of synapses decreases.
with
Cln7
without
Cln7
Cln7 lost
then replaced
When we put the gene back the
nerve returns to normal size.
This is an important test
because it shows the change in
nerve size is caused by losing
the Cln7 gene.
We can also see that the nerve no longer works properly.
We are now trying to work out why these things happen.
If we can find that out we will learn a lot about how Cln7
works.
We will also need to see if the size of nerves changes in
mice without any Cln7.
6
Conclusions
Before we can start to develop therapies we need to
understand why neurodegeneration occurs in patients with
Cln7 mutations. But at present we don’t know anything
about what Cln7 does or how it might do it.
We are using a fruit flies as a simple animal model to ask
two key questions:
What does Cln7 do in nerve cells?
What happens to nerve cells when Cln7 is mutated?
If you would like further information about this project
please contact us:
Richard Tuxworth r.i.tuxworth@bham.ac.uk
Guy Tear guy.tear@kcl.ac.uk

Weitere ähnliche Inhalte

Was ist angesagt?

Dogma central
Dogma centralDogma central
Dogma central
Camilajaramilloj
 
Schadt ad webinar (23 may 2013)
Schadt ad webinar (23 may 2013)Schadt ad webinar (23 may 2013)
Schadt ad webinar (23 may 2013)
Alzforum
 
Jocelyn abstract conference Jan 2016
Jocelyn abstract conference Jan 2016Jocelyn abstract conference Jan 2016
Jocelyn abstract conference Jan 2016
Jocelyn Delhotal
 
Muthusamy_et_al-2015-Aging_Cell
Muthusamy_et_al-2015-Aging_CellMuthusamy_et_al-2015-Aging_Cell
Muthusamy_et_al-2015-Aging_Cell
Laura Sommerville
 
“HOW SOME UNUSUAL RNA MOLECULES HOME IN ON TARGETS ” AND “UNIQUE EPIGENOMIC ...
“HOW SOME UNUSUAL RNA MOLECULES  HOME IN ON TARGETS ” AND “UNIQUE EPIGENOMIC ...“HOW SOME UNUSUAL RNA MOLECULES  HOME IN ON TARGETS ” AND “UNIQUE EPIGENOMIC ...
“HOW SOME UNUSUAL RNA MOLECULES HOME IN ON TARGETS ” AND “UNIQUE EPIGENOMIC ...
Camilo Usuga
 

Was ist angesagt? (20)

2016 BDSRA Cooper CLN1, CLN2, CLN3, CLN5, CLN6, CLN7
2016 BDSRA Cooper CLN1, CLN2, CLN3, CLN5, CLN6, CLN72016 BDSRA Cooper CLN1, CLN2, CLN3, CLN5, CLN6, CLN7
2016 BDSRA Cooper CLN1, CLN2, CLN3, CLN5, CLN6, CLN7
 
2016 BDSRA Mole CLN1, CLN2, CLN3, CLN5, CLN6, CLN7,
2016 BDSRA Mole CLN1, CLN2, CLN3, CLN5, CLN6, CLN7,2016 BDSRA Mole CLN1, CLN2, CLN3, CLN5, CLN6, CLN7,
2016 BDSRA Mole CLN1, CLN2, CLN3, CLN5, CLN6, CLN7,
 
BDSRA 2015 CLN1 Hofmann
BDSRA 2015 CLN1 HofmannBDSRA 2015 CLN1 Hofmann
BDSRA 2015 CLN1 Hofmann
 
BDSRA 2015 CLN1 CLN2 CLN3 Sleat, Lobel
BDSRA 2015 CLN1 CLN2 CLN3 Sleat, Lobel BDSRA 2015 CLN1 CLN2 CLN3 Sleat, Lobel
BDSRA 2015 CLN1 CLN2 CLN3 Sleat, Lobel
 
Dogma central
Dogma centralDogma central
Dogma central
 
2014 BDSRA Stein and Davidson JNCL
2014 BDSRA Stein and Davidson JNCL2014 BDSRA Stein and Davidson JNCL
2014 BDSRA Stein and Davidson JNCL
 
Marc Dhenain Alzforum Webinar - Dec 7, 2016
Marc Dhenain Alzforum Webinar - Dec 7, 2016Marc Dhenain Alzforum Webinar - Dec 7, 2016
Marc Dhenain Alzforum Webinar - Dec 7, 2016
 
Jncl kielian2
Jncl kielian2Jncl kielian2
Jncl kielian2
 
Cliff Brangwynne
Cliff BrangwynneCliff Brangwynne
Cliff Brangwynne
 
2014 BDSRA Davidson LINCL
2014 BDSRA Davidson LINCL2014 BDSRA Davidson LINCL
2014 BDSRA Davidson LINCL
 
2014 BDSRA Micsenyi LINCL and JNCL
2014 BDSRA Micsenyi LINCL and JNCL2014 BDSRA Micsenyi LINCL and JNCL
2014 BDSRA Micsenyi LINCL and JNCL
 
Schadt ad webinar (23 may 2013)
Schadt ad webinar (23 may 2013)Schadt ad webinar (23 may 2013)
Schadt ad webinar (23 may 2013)
 
The cellular phase of Alzheimer's disease
The cellular phase of Alzheimer's diseaseThe cellular phase of Alzheimer's disease
The cellular phase of Alzheimer's disease
 
Faithful cell division requires tightly controlled protein placement
Faithful cell division requires tightly controlled protein placementFaithful cell division requires tightly controlled protein placement
Faithful cell division requires tightly controlled protein placement
 
Stem cells & Neurodegenerative diseases And Some clinical CNS
Stem cells & Neurodegenerative diseases And Some clinical CNSStem cells & Neurodegenerative diseases And Some clinical CNS
Stem cells & Neurodegenerative diseases And Some clinical CNS
 
Jocelyn abstract conference Jan 2016
Jocelyn abstract conference Jan 2016Jocelyn abstract conference Jan 2016
Jocelyn abstract conference Jan 2016
 
Mark Daly - Finding risk genes in psychiatric disorders
Mark Daly - Finding risk genes in psychiatric disordersMark Daly - Finding risk genes in psychiatric disorders
Mark Daly - Finding risk genes in psychiatric disorders
 
Lincl katz
Lincl katzLincl katz
Lincl katz
 
Muthusamy_et_al-2015-Aging_Cell
Muthusamy_et_al-2015-Aging_CellMuthusamy_et_al-2015-Aging_Cell
Muthusamy_et_al-2015-Aging_Cell
 
“HOW SOME UNUSUAL RNA MOLECULES HOME IN ON TARGETS ” AND “UNIQUE EPIGENOMIC ...
“HOW SOME UNUSUAL RNA MOLECULES  HOME IN ON TARGETS ” AND “UNIQUE EPIGENOMIC ...“HOW SOME UNUSUAL RNA MOLECULES  HOME IN ON TARGETS ” AND “UNIQUE EPIGENOMIC ...
“HOW SOME UNUSUAL RNA MOLECULES HOME IN ON TARGETS ” AND “UNIQUE EPIGENOMIC ...
 

Ähnlich wie Vlincl tuxworth

Detail The Components Of A Synapse And Describe The...
Detail The Components Of A Synapse And Describe The...Detail The Components Of A Synapse And Describe The...
Detail The Components Of A Synapse And Describe The...
Jennifer Perry
 
What is going on in psychiatry when nothing seems to happen
What is going on in psychiatry when nothing seems to happenWhat is going on in psychiatry when nothing seems to happen
What is going on in psychiatry when nothing seems to happen
Adonis Sfera, MD
 
10 Neurons & Intro to Nervous
10 Neurons & Intro to Nervous10 Neurons & Intro to Nervous
10 Neurons & Intro to Nervous
Mrs. Taber
 
Courtesy Dr. Julie Gralow1LO 1 Define neuroscience a.docx
Courtesy Dr. Julie Gralow1LO 1 Define neuroscience a.docxCourtesy Dr. Julie Gralow1LO 1 Define neuroscience a.docx
Courtesy Dr. Julie Gralow1LO 1 Define neuroscience a.docx
vanesaburnand
 
Juan-Rodriguez-SCIA-AutismOne-2013 (1)
Juan-Rodriguez-SCIA-AutismOne-2013 (1)Juan-Rodriguez-SCIA-AutismOne-2013 (1)
Juan-Rodriguez-SCIA-AutismOne-2013 (1)
Juan Rodriguez
 

Ähnlich wie Vlincl tuxworth (17)

Neuron Research Paper
Neuron Research PaperNeuron Research Paper
Neuron Research Paper
 
Detail The Components Of A Synapse And Describe The...
Detail The Components Of A Synapse And Describe The...Detail The Components Of A Synapse And Describe The...
Detail The Components Of A Synapse And Describe The...
 
Neuromarketing
NeuromarketingNeuromarketing
Neuromarketing
 
What is going on in psychiatry when nothing seems to happen
What is going on in psychiatry when nothing seems to happenWhat is going on in psychiatry when nothing seems to happen
What is going on in psychiatry when nothing seems to happen
 
Your brain a_matter_of_time
Your brain a_matter_of_timeYour brain a_matter_of_time
Your brain a_matter_of_time
 
Neurons , Neurogenesis
Neurons  , NeurogenesisNeurons  , Neurogenesis
Neurons , Neurogenesis
 
Neuronal cell tumors
Neuronal cell tumorsNeuronal cell tumors
Neuronal cell tumors
 
A Matter of Time: 9 things you should know about your brain
A Matter of Time: 9 things you should know about your brainA Matter of Time: 9 things you should know about your brain
A Matter of Time: 9 things you should know about your brain
 
The Nervous System.ppt
The Nervous System.pptThe Nervous System.ppt
The Nervous System.ppt
 
How microglia are involved in Alzheimer's disease
How microglia are involved in Alzheimer's diseaseHow microglia are involved in Alzheimer's disease
How microglia are involved in Alzheimer's disease
 
neuroplasticity.pdf
neuroplasticity.pdfneuroplasticity.pdf
neuroplasticity.pdf
 
10 Neurons & Intro to Nervous
10 Neurons & Intro to Nervous10 Neurons & Intro to Nervous
10 Neurons & Intro to Nervous
 
Courtesy Dr. Julie Gralow1LO 1 Define neuroscience a.docx
Courtesy Dr. Julie Gralow1LO 1 Define neuroscience a.docxCourtesy Dr. Julie Gralow1LO 1 Define neuroscience a.docx
Courtesy Dr. Julie Gralow1LO 1 Define neuroscience a.docx
 
The nervoussystem
The nervoussystemThe nervoussystem
The nervoussystem
 
Neuroplasticity and anesthesia
Neuroplasticity and anesthesia Neuroplasticity and anesthesia
Neuroplasticity and anesthesia
 
The nervoussystem
The nervoussystemThe nervoussystem
The nervoussystem
 
Juan-Rodriguez-SCIA-AutismOne-2013 (1)
Juan-Rodriguez-SCIA-AutismOne-2013 (1)Juan-Rodriguez-SCIA-AutismOne-2013 (1)
Juan-Rodriguez-SCIA-AutismOne-2013 (1)
 

Mehr von Batten Disease Support and Research Association

Mehr von Batten Disease Support and Research Association (20)

2018 BDSRA Gayko
2018 BDSRA Gayko2018 BDSRA Gayko
2018 BDSRA Gayko
 
2018 BDSRA Whiting CLN2
2018 BDSRA Whiting CLN22018 BDSRA Whiting CLN2
2018 BDSRA Whiting CLN2
 
2018 BDSRA Vierhile
2018 BDSRA Vierhile2018 BDSRA Vierhile
2018 BDSRA Vierhile
 
2018 BDSRA Storch CLN7
2018 BDSRA Storch CLN72018 BDSRA Storch CLN7
2018 BDSRA Storch CLN7
 
2018 BDSRA Gray CLN1
2018 BDSRA Gray CLN12018 BDSRA Gray CLN1
2018 BDSRA Gray CLN1
 
2018 BDSRA Hughes CLN6
2018 BDSRA Hughes CLN62018 BDSRA Hughes CLN6
2018 BDSRA Hughes CLN6
 
2018 BDSRA Roine CLN3
2018 BDSRA Roine CLN32018 BDSRA Roine CLN3
2018 BDSRA Roine CLN3
 
2018 BDSRA Roberge
2018 BDSRA Roberge 2018 BDSRA Roberge
2018 BDSRA Roberge
 
2018 BDSRA Circumvent Pharmaceuticals CLN1
2018 BDSRA Circumvent Pharmaceuticals CLN12018 BDSRA Circumvent Pharmaceuticals CLN1
2018 BDSRA Circumvent Pharmaceuticals CLN1
 
2018 BDSRA Cooper, Nelvagal
2018 BDSRA Cooper, Nelvagal2018 BDSRA Cooper, Nelvagal
2018 BDSRA Cooper, Nelvagal
 
2018 BDSRA Feuerborn
2018 BDSRA Feuerborn2018 BDSRA Feuerborn
2018 BDSRA Feuerborn
 
2018 BDSRA Cotman MGH Center for Genomic Medicine
2018 BDSRA Cotman MGH Center for Genomic Medicine2018 BDSRA Cotman MGH Center for Genomic Medicine
2018 BDSRA Cotman MGH Center for Genomic Medicine
 
2018 BDSRA Cotman CLN3
2018 BDSRA Cotman CLN32018 BDSRA Cotman CLN3
2018 BDSRA Cotman CLN3
 
2018 BDSRA Dang Do CLN3
2018 BDSRA Dang Do CLN32018 BDSRA Dang Do CLN3
2018 BDSRA Dang Do CLN3
 
2017 BDSRA Whiting and Katz CLN2
2017 BDSRA Whiting and Katz CLN22017 BDSRA Whiting and Katz CLN2
2017 BDSRA Whiting and Katz CLN2
 
2017 BDSRA Tammen, Grupen, James and Delerue CLN6 CLN7
2017 BDSRA Tammen, Grupen, James and Delerue CLN6 CLN72017 BDSRA Tammen, Grupen, James and Delerue CLN6 CLN7
2017 BDSRA Tammen, Grupen, James and Delerue CLN6 CLN7
 
2017 BDSRA Storch and Danyukova CLN7
2017 BDSRA Storch and Danyukova CLN72017 BDSRA Storch and Danyukova CLN7
2017 BDSRA Storch and Danyukova CLN7
 
2017 BDSRA Stehr and van der Putten, CLN3
2017 BDSRA Stehr and van der Putten, CLN32017 BDSRA Stehr and van der Putten, CLN3
2017 BDSRA Stehr and van der Putten, CLN3
 
2017 BDSRA Autti, U. Roine, T. Roine, Aberg, Tokola, Balk, Hakkarainen, Manne...
2017 BDSRA Autti, U. Roine, T. Roine, Aberg, Tokola, Balk, Hakkarainen, Manne...2017 BDSRA Autti, U. Roine, T. Roine, Aberg, Tokola, Balk, Hakkarainen, Manne...
2017 BDSRA Autti, U. Roine, T. Roine, Aberg, Tokola, Balk, Hakkarainen, Manne...
 
2017 BDSRA Trometer, Potier, Cournoyer, and Schermer
2017 BDSRA Trometer, Potier, Cournoyer, and Schermer2017 BDSRA Trometer, Potier, Cournoyer, and Schermer
2017 BDSRA Trometer, Potier, Cournoyer, and Schermer
 

Vlincl tuxworth

  • 1. Synaptic Changes in Neuronal Ceroid Lipofuscinosis Variant Infantile Batten Disease Richard Tuxworth, University of Birmingham, UK. r.i.tuxworth@bham.ac.uk Megan O’Hare & Guy Tear, King’s College London, UK. guy.tear@kcl.ac.uk What are synapses? The brain contains billions of nerve cells. Each makes thousands of connections with neighbours at structures called synapses. When an electrical impulse arrives at a synapse special chemicals are released. These are called neurotransmitters. The chemicals cross over to the neighbouring nerve cell. There are several types of neurotransmitter chemicals. Some “excite” the neighbour, other “inhibit” the neighbour. If enough “exciting” chemicals arrive in a short space of time, the neighbour will “fire” and an electrical signal passes along the nerve cell. 1 2 Why are synapses interesting to study? 1. For neurodegenerative diseases Synapses are one of the first things to be affected in neurodegeneration diseases. This happens in all forms of neurodegeneration including inherited forms like NCL and late onset forms like Alzheimer’s disease. We need to understand what is happening and why to help design effective therapies. 2. For developmental disorders Synapses are changed in some developmental disorders such as autism. Changes occur during foetal development or very early in childhood. In some forms of autism nerve cells grow too big and have too many synapses. We don’t understand why this leads to the behavioural differences in autism. In neurodegenerative diseases with very early onset (like the infantile forms of NCLs) the changes to synapses must start very early on? Can we see any similarities to the changes in developmental disorders? 3 How do we study synaptic change? Many NCL studies use mice to help understand the disease. A mouse brain is much less complex than a human’s but still contains many billions of synapses. As a simpler alternative, we are using fruit flies to look for synaptic changes in NCL. Fruit flies have a much smaller and simpler nervous system than a mammal but their nerve cells work identically. With fruit flies we can also use powerful genetic tools. This allows us to manipulate their genes in ways that are not possible with mice. 4 What are we doing? We made a fruit fly mutant which does not have the Cln7 gene. We can are look at one particular nerve and see if the number of synapses has changed. We dissect the fruit flies when they are maggots. Then we look at the nerves by microscopy. The synapses are the small red dots. More than 5,000 would fit on a pin head. The rest of the nerve is shown in green. We use software to count the synapses and measure the size of the nerve. 5 What happens when there is no Cln7 ? In flies without a Cln7 gene the nerve gets smaller and the number of synapses decreases. with Cln7 without Cln7 Cln7 lost then replaced When we put the gene back the nerve returns to normal size. This is an important test because it shows the change in nerve size is caused by losing the Cln7 gene. We can also see that the nerve no longer works properly. We are now trying to work out why these things happen. If we can find that out we will learn a lot about how Cln7 works. We will also need to see if the size of nerves changes in mice without any Cln7. 6 Conclusions Before we can start to develop therapies we need to understand why neurodegeneration occurs in patients with Cln7 mutations. But at present we don’t know anything about what Cln7 does or how it might do it. We are using a fruit flies as a simple animal model to ask two key questions: What does Cln7 do in nerve cells? What happens to nerve cells when Cln7 is mutated? If you would like further information about this project please contact us: Richard Tuxworth r.i.tuxworth@bham.ac.uk Guy Tear guy.tear@kcl.ac.uk